| OSTERBORG, A., R.C. JEWELL, S. PADMANABHAN-IYER, T.J. KIPPS, Jiří MAYER, S. STILGENBAUER, C.D. WILLIAMS, A. HELLMANN, R.R. FURMAN, T. ROBAK, P. HILLMAN, M. TRNENY, M.J.S. DYER, M. PIOTROWSKA, T. KOZAK, I.V. GUPTA, J.L. PHILLIPS, N. GOLDSTEIN, H. STRUEMPER, N. LOSIC, S. LISBY a W.G. WIERDA. Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study. Haematologica. Pavia: Ferrata Storti Foundation, 2015, roč. 100, č. 8, s. "E311"-"E314", 4 s. ISSN 0390-6078. Dostupné z: https://dx.doi.org/10.3324/haematol.2014.121459. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1334133,
author = {Osterborg, A. and Jewell, R.C. and PadmanabhanandIyer, S. and Kipps, T.J. and Mayer, Jiří and Stilgenbauer, S. and Williams, C.D. and Hellmann, A. and Furman, R.R. and Robak, T. and Hillman, P. and Trneny, M. and Dyer, M.J.S. and Piotrowska, M. and Kozak, T. and Gupta, I.V. and Phillips, J.L. and Goldstein, N. and Struemper, H. and Losic, N. and Lisby, S. and Wierda, W.G.},
article_location = {Pavia},
article_number = {8},
doi = {http://dx.doi.org/10.3324/haematol.2014.121459},
keywords = {ofatumumab; fludarabine-refractory; pivotal study},
language = {eng},
issn = {0390-6078},
journal = {Haematologica},
title = {Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study},
volume = {100},
year = {2015}
}
TY - JOUR
ID - 1334133
AU - Osterborg, A. - Jewell, R.C. - Padmanabhan-Iyer, S. - Kipps, T.J. - Mayer, Jiří - Stilgenbauer, S. - Williams, C.D. - Hellmann, A. - Furman, R.R. - Robak, T. - Hillman, P. - Trneny, M. - Dyer, M.J.S. - Piotrowska, M. - Kozak, T. - Gupta, I.V. - Phillips, J.L. - Goldstein, N. - Struemper, H. - Losic, N. - Lisby, S. - Wierda, W.G.
PY - 2015
TI - Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study
JF - Haematologica
VL - 100
IS - 8
SP - "E311"-"E314"
EP - "E311"-"E314"
PB - Ferrata Storti Foundation
SN - 03906078
KW - ofatumumab
KW - fludarabine-refractory
KW - pivotal study
N2 - Study of Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study.
ER -
OSTERBORG, A., R.C. JEWELL, S. PADMANABHAN-IYER, T.J. KIPPS, Jiří MAYER, S. STILGENBAUER, C.D. WILLIAMS, A. HELLMANN, R.R. FURMAN, T. ROBAK, P. HILLMAN, M. TRNENY, M.J.S. DYER, M. PIOTROWSKA, T. KOZAK, I.V. GUPTA, J.L. PHILLIPS, N. GOLDSTEIN, H. STRUEMPER, N. LOSIC, S. LISBY a W.G. WIERDA. Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study. \textit{Haematologica}. Pavia: Ferrata Storti Foundation, 2015, roč.~100, č.~8, s.~''E311''-''E314'', 4 s. ISSN~0390-6078. Dostupné z: https://dx.doi.org/10.3324/haematol.2014.121459.
|
